Series D extends runway into 2027, advancing first-in-class c-mod DPTX3186 toward proof-of-concept in gastric cancer.Strong ...

AI-leveraged drug development has become an $18 billion industry, but companies in the sector are experiencing some hardships ...

Novonesis and Novo Nordisk have formed a research partnership to study how the gut microbiome can support metabolic health and help prevent obesi ...

Hong Kong, November 9, 2020] Deqi Pharmaceutical Co., Ltd. (" Deqi Pharmaceutical " or " the Company ", together with its subsidiaries, collectively referred to as " the Group "; Stock Code: 6996.HK ) ...

While McAlester residents voting Tuesday, Sept. 9, 2025, on a school bond, a Stillwater homeowner's association is taking ...

Regenxbio's RGX-121 gene therapy for Hunter syndrome is the main catalyst, with FDA approval targeted for February 2026.